Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / GOSS - Lyra Therapeutics Aims For U.S. IPO In Choppy Market

GOSS - Lyra Therapeutics Aims For U.S. IPO In Choppy Market

Gossamer Bio Inc.

Quick Take

Lyra Therapeutics (LYRA) has filed to raise $57.5 million in an IPO of its common stock, according to an S-1 registration statement.

The company is advancing a pipeline of treatment candidates for chronic rhinosinusitis patients.

LYRA is in Phase 2 trials for its lead candidate and expects initial topline data readout in Q1 2021.

I’ll provide an update when we learn more IPO pricing and valuation details from management.

Company & Technology

Watertown, Massachusetts-based Lyra was founded to develop drug treatments for two types of patients with chronic rhinosinusitis, those

Read more ...
Stock Information
Company Name: Gossamer Bio Inc.
Stock Symbol: GOSS
Market: NYSE
Website: gossamerbio.com
Menu
GOSS GOSS Quote GOSS Short GOSS News GOSS Articles GOSS Message Board
Get GOSS Alerts

News, Short Squeeze, Breakout and More Instantly...